Neurogene Inc.
NLTX
Revenue
925.00k
▲925.00k∞%
12 Months ChangeAssets
179.82M
▼-15.53M▼-7.95%
3 Months ChangeLiabilities
24.81M
▲236.00k▲0.9604%
3 Months ChangeFree Cash Flow
-21.72M
▼-8.13M▼-59.86%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-06-21
Form 8-K
ID: 0001404644-24-000080
2024-06-18
Form 8-K
ID: 0001404644-24-000073
2024-06-17
Form 8-K
ID: 0001404644-24-000066
2024-06-03
Form 8-K
ID: 0001404644-24-000059
2024-05-10
Form 10-Q
ID: 0001404644-24-000057
2024-05-10
Form 8-K
ID: 0001404644-24-000054
2024-05-07
Form 8-K
ID: 0001404644-24-000049
2024-04-25
Form 8-K
ID: 0001404644-24-000041
2024-04-22
Form 8-K
ID: 0001404644-24-000029
2024-04-02
Form 8-K
ID: 0001404644-24-000026